Ginkgo's platform has been used successfully by Cronos to achieve the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid often associated with reducing appetite.
The Gingko / Cronos partnership started in 2018 and has a stated aim to produce cultured cannabinoids at industrial scale.
Ginkgo has considerable experience designing microorganisms for the production of cultured products across pharmaceuticals, agriculture and more.
In August 2021, Ginkgo and Cronos achieved milestone #1 for cannabigerolic acid (CBGA).
In October 2021, Cronos launched the SPINACH FEELZ™ Chill Bliss 2:1 THC|CGB gummy and the SPINACH FEELZ™ Chill Bliss 7:1 THC|CBG vape in January 2022.